Loading...
Loading...
Contributors:
Dataset URI:
10.1371/journal.pone.0319063.t002Under the pressure of transformation and upgrading caused by complex environments at home and abroad, it is significant to explore how the centralized allocation of decision rights affects enterprise transformation and upgrading. Employing the data of Chinese A-share listed companies from 2010 to 2021, we demonstrate that the centralized allocation of decision rights significantly promotes enterprise transformation and upgrading. Further analysis indicates that enhanced human capital level and capital allocation efficiency are potential mechanisms through which centralized allocation of decision rights affects enterprise transformation and upgrading. Moreover, we document that the above positive correlation is more evident for groups with a high matching between cash flow rights and control rights, groups with strong supervision of major shareholders, and groups with a strong willingness of subsidiaries to cooperate. Collectively, these findings confirm the governance advantages of the centralized allocation of decision rights and provide important implications for enterprises’ transformation and upgrading in emerging market countries.
Keyword(s):
analysis indicates; Biological Sciences not elsewhere classified; Biotechnology; Cancer; capital allocation efficiency.
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)